Nothing Special   »   [go: up one dir, main page]

BG108355A - Galantamin-based combined medicamentous product - Google Patents

Galantamin-based combined medicamentous product

Info

Publication number
BG108355A
BG108355A BG108355A BG10835503A BG108355A BG 108355 A BG108355 A BG 108355A BG 108355 A BG108355 A BG 108355A BG 10835503 A BG10835503 A BG 10835503A BG 108355 A BG108355 A BG 108355A
Authority
BG
Bulgaria
Prior art keywords
galantamin
medicamentous
product
based combined
combined
Prior art date
Application number
BG108355A
Other languages
Bulgarian (bg)
Other versions
BG65658B1 (en
Inventor
Ангел ТИМЧЕВ
Райна БАЛТАДЖИЕВА-РАЙЧЕВА
Виолета ПАВЛОВА
Веселин ДАСКАЛОВ
Радка ГРОЗДЕВА
Стилиян СИМЕОНОВ
Добрина ДОБРЕВА
Мариана НИКОЛОВА
Original Assignee
"Софарма" Ад
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Софарма" Ад filed Critical "Софарма" Ад
Priority to BG108355A priority Critical patent/BG65658B1/en
Publication of BG108355A publication Critical patent/BG108355A/en
Publication of BG65658B1 publication Critical patent/BG65658B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a combined medicamentous product comprising galantamin and vitamins of group B, including B1, B2, B5, B6 and vitamin PP. The combined preparation shall find application in the treatment and prevention of the central and the peripheral nervous systems.
BG108355A 2003-11-13 2003-11-13 Galantamin-based combined medicamentous product BG65658B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG108355A BG65658B1 (en) 2003-11-13 2003-11-13 Galantamin-based combined medicamentous product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG108355A BG65658B1 (en) 2003-11-13 2003-11-13 Galantamin-based combined medicamentous product

Publications (2)

Publication Number Publication Date
BG108355A true BG108355A (en) 2005-05-31
BG65658B1 BG65658B1 (en) 2009-05-29

Family

ID=34624294

Family Applications (1)

Application Number Title Priority Date Filing Date
BG108355A BG65658B1 (en) 2003-11-13 2003-11-13 Galantamin-based combined medicamentous product

Country Status (1)

Country Link
BG (1) BG65658B1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
DE4010079A1 (en) * 1990-03-29 1991-10-02 Lohmann Therapie Syst Lts PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF ALCOHOLISM
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
DE4301782C1 (en) * 1993-01-23 1994-08-25 Lohmann Therapie Syst Lts Use of galanthamine to treat nicotine addiction

Also Published As

Publication number Publication date
BG65658B1 (en) 2009-05-29

Similar Documents

Publication Publication Date Title
MXPA05010565A (en) Drug delivery systems comprising an encapsulated active ingredient.
ZA200307241B (en) Nutritional supplement to treat macular degeneration.
PT703786E (en) USE OF NONAPEPTIDEES AND DECAPEPTIDEOS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AIDS
TW200637522A (en) Skin treatment articles and methods
GB2333453A (en) Colostrinin and uses thereof
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
EP1435982A4 (en) Delivery system for pharmaceutical, nutritional and cosmetic ingredients
WO2001091770A3 (en) Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
MXPA06000464A (en) Use of biotin or a biotin derivative for lightening skin and treating age spots.
WO2003088748A8 (en) Use of heme oxygenase-1 and products of heme degradation
AU2003223989A1 (en) System for orally administering active substances, vitamins and/or foodstuffs
WO2009118726A3 (en) Oral combination of vitamins
MXPA03008420A (en) Solid orally-dispersible pharmaceutical formulation.
TW200602073A (en) Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a DPP-IV mediated condition
WO2003068231A3 (en) Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof
UA88165C2 (en) Use of trisubstituted benzopyranones
MXPA02011465A (en) Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same.
BG108355A (en) Galantamin-based combined medicamentous product
WO2004006830A3 (en) Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux
WO2002054881A3 (en) The use of food and drink as a delevery system for phytase in humans
AU2001275145A1 (en) Compositions for treating brain disorders and enhancing brain function, containing herbals and/or nutritional supplements and/or minerals and/or vitamins
AU4910500A (en) Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
GB2443377A (en) Anti-malarial composition comprising artesunate and lumefantrine
AU2003234084A1 (en) Creatine salt having enhanced nutritional, antioxidant and therapeutic efficacy and compositions containing same
WO2002087604A3 (en) Preparations containing a combination of vitamin e and afamin